The potential impact of digital biomarkers in multiple sclerosis in the netherlands:An early health technology assessment of ms sherpa
(1) Background: Monitoring of Multiple Sclerosis (MS) with eHealth interventions or digital biomarkers provides added value to the current care path. Evidence in the literature is currently scarce. MS sherpa is an eHealth intervention with digital biomarkers, aimed at monitoring symptom progression and disease activity. To show the added value of digital biomarker–based eHealth interventions to the MS care path, an early Health Technology Assessment (eHTA) was performed, with MS sherpa as an example, to assess the potential impact on treatment switches. (2) Methods: The eHTA was performed acco... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Reihe/Periodikum: | Cloosterman , S , Wijnands , I , Huygens , S , Wester , V , Lam , K H , Strijbis , E , Teuling , B D & Versteegh , M 2021 , ' The potential impact of digital biomarkers in multiple sclerosis in the netherlands : An early health technology assessment of ms sherpa ' , Brain Sciences , vol. 11 , no. 10 , 1305 . https://doi.org/10.3390/brainsci11101305 |
Schlagwörter: | /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being / name=SDG 3 - Good Health and Well-being |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27615952 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://pure.eur.nl/en/publications/39f19aa6-ee32-4733-af44-33d2440e185a |